FDA Inspection 859011 — Lincare Inc.

Lincare Inc. — FEI 3002726192

The FDA completed an inspection of Lincare Inc. on Dec 12, 2013 in Saint Paul, MN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 12, 2013
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Saint Paul, MN (United States)